This study is for adults 18 years or older with Graves' disease, a condition where the thyroid gland is overactive. Some participants might also have Graves' orbitopathy, which affects the eyes. The study will check how safe and effective an investigational medication is for these conditions.
Study Details:
- The study lasts up to 24 weeks, including screening, treatment, and follow-up periods.
- You'll visit the study site up to 13 times.
- Participants must use contraception as per local guidelines.
Eligibility: You must have active Graves' disease. Some participants will also have active Graves' orbitopathy with specific symptoms like eye issues. You cannot have other types of hyperthyroidism, recent eye surgeries, or severe eye conditions.
If you have questions, talk to your doctor to see if this study is right for you. Remember, this is a research study to explore the safety and effects of the investigational medication, and participation is entirely voluntary.
